berberine has been researched along with Idiopathic Parkinson Disease in 9 studies
Excerpt | Relevance | Reference |
---|---|---|
"Berberine (BBR) is an organic small molecule isolated from various plants that have been used in traditional Chinese medicine." | 6.52 | Therapeutic potential of berberine against neurodegenerative diseases. ( Jiang, W; Li, S; Li, X, 2015) |
"Berberine is an isoquinoline alkaloid that has shown promise as a pharmacological treatment in PD, given its ability to modulate several molecular pathway associated with the disease." | 2.82 | Can Berberine Serve as a New Therapy for Parkinson's Disease? ( Aschner, M; Dadgostar, E; Khandan, M; Mirzaei, H; Moghanlou, M; Mohammadi, S; Parvaresh, M; Tamtaji, OR, 2022) |
"Berberine (BBR) is an organic small molecule isolated from various plants that have been used in traditional Chinese medicine." | 2.52 | Therapeutic potential of berberine against neurodegenerative diseases. ( Jiang, W; Li, S; Li, X, 2015) |
"One of the treatment strategies for Parkinson's disease involves the use of drugs that aim to increase dopamine levels or simulate the action of dopamine in the brain." | 1.91 | DFT, ADME studies and evaluation of the binding with HSA and MAO-B inhibitory potential of protoberberine alkaloids from Guatteria friesiana: theoretical insights of promising candidates for the treatment of Parkinson's disease. ( Costa, EV; Costa, RA; Mary, YS; S Al-Otaibi, J; Tananta, VL, 2023) |
"Berberine is a famous alkaloid extracted from Berberis plants and has been widely used as medications and functional food additives." | 1.62 | Treatment of Parkinson's disease in Zebrafish model with a berberine derivative capable of crossing blood brain barrier, targeting mitochondria, and convenient for bioimaging experiments. ( Jin, M; Liu, K; Liu, X; Ren, Q; Shang, X; Sheng, W; Stoika, R; Tan, Z; Wang, L; Wang, R, 2021) |
"Treatment with berberine also improved short-term memory by inhibiting apoptosis in the hippocampus." | 1.40 | Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease. ( Cho, HS; Cho, KH; Kim, CJ; Kim, M; Lee, JM; Shin, DH; Shin, MS; Yang, HJ, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 5 (55.56) | 2.80 |
Authors | Studies |
---|---|
Dadgostar, E | 1 |
Moghanlou, M | 1 |
Parvaresh, M | 1 |
Mohammadi, S | 1 |
Khandan, M | 1 |
Aschner, M | 1 |
Mirzaei, H | 1 |
Tamtaji, OR | 1 |
Li, J | 1 |
Meng, P | 1 |
Zhang, J | 1 |
He, M | 1 |
Tananta, VL | 1 |
Costa, EV | 1 |
Mary, YS | 2 |
S Al-Otaibi, J | 1 |
Costa, RA | 1 |
Wang, Y | 1 |
Tong, Q | 1 |
Ma, SR | 1 |
Zhao, ZX | 1 |
Pan, LB | 1 |
Cong, L | 1 |
Han, P | 1 |
Peng, R | 1 |
Yu, H | 1 |
Lin, Y | 1 |
Gao, TL | 1 |
Shou, JW | 1 |
Li, XY | 1 |
Zhang, XF | 1 |
Zhang, ZW | 1 |
Fu, J | 1 |
Wen, BY | 1 |
Yu, JB | 1 |
Cao, X | 1 |
Jiang, JD | 1 |
Wang, L | 1 |
Sheng, W | 1 |
Tan, Z | 1 |
Ren, Q | 1 |
Wang, R | 1 |
Stoika, R | 1 |
Liu, X | 1 |
Liu, K | 1 |
Shang, X | 1 |
Jin, M | 1 |
Ribaudo, G | 1 |
Zanforlin, E | 1 |
Canton, M | 1 |
Bova, S | 1 |
Zagotto, G | 1 |
Kim, M | 1 |
Cho, KH | 1 |
Shin, MS | 1 |
Lee, JM | 1 |
Cho, HS | 1 |
Kim, CJ | 1 |
Shin, DH | 1 |
Yang, HJ | 1 |
Jiang, W | 1 |
Li, S | 1 |
Li, X | 1 |
Mo, J | 1 |
Guo, Y | 1 |
Yang, YS | 1 |
Shen, JS | 1 |
Jin, GZ | 1 |
Zhen, X | 1 |
3 reviews available for berberine and Idiopathic Parkinson Disease
Article | Year |
---|---|
Can Berberine Serve as a New Therapy for Parkinson's Disease?
Topics: alpha-Synuclein; Autophagy; Berberine; Dopaminergic Neurons; Humans; Neurodegenerative Diseases; Oxi | 2022 |
Therapeutic potential of berberine against neurodegenerative diseases.
Topics: Alzheimer Disease; Animals; Berberine; Blood-Brain Barrier; Disease Models, Animal; Humans; Medicine | 2015 |
Recent developments in studies of l-stepholidine and its analogs: chemistry, pharmacology and clinical implications.
Topics: Berberine; Berberine Alkaloids; Dopamine; Humans; Mental Disorders; Parkinson Disease; Receptors, Do | 2007 |
1 trial available for berberine and Idiopathic Parkinson Disease
Article | Year |
---|---|
Effect of Berberine Hydrochloride on the Diversity of Intestinal Flora in Parkinson's Disease Patients.
Topics: Berberine; Gastrointestinal Microbiome; Humans; Interleukin-6; Interleukin-8; Parkinson Disease; RNA | 2022 |
5 other studies available for berberine and Idiopathic Parkinson Disease
Article | Year |
---|---|
DFT, ADME studies and evaluation of the binding with HSA and MAO-B inhibitory potential of protoberberine alkaloids from Guatteria friesiana: theoretical insights of promising candidates for the treatment of Parkinson's disease.
Topics: Berberine; Dopamine; Guatteria; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; | 2023 |
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.
Topics: Animals; Berberine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Enterococcus faecalis; Entero | 2021 |
Treatment of Parkinson's disease in Zebrafish model with a berberine derivative capable of crossing blood brain barrier, targeting mitochondria, and convenient for bioimaging experiments.
Topics: Animals; Berberine; Blood-Brain Barrier; Brain; Disease Models, Animal; Dopaminergic Neurons; Dose-R | 2021 |
Preliminary studies of berberine and its semi-synthetic derivatives as a promising class of multi-target anti-parkinson agents.
Topics: Antiparkinson Agents; Berberine; Computer Simulation; Drug Evaluation, Preclinical; Humans; Magnetic | 2018 |
Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Berberine; Caspase 3; Dentate Gyrus; DNA Fragmentati | 2014 |